Navigation Links
Genstar Capital Announces Acquisition of Tecomet
Date:12/19/2013

SAN FRANCISCO, Dec. 19, 2013 /PRNewswire/ -- Genstar Capital Management, LLC, a middle market private equity firm that focuses on investments in selected segments of the industrial technology, healthcare, financial services, and software industries, announced today the acquisition of Tecomet, Inc., a leading precision contract manufacturer supporting the medical device and aerospace & defense industries, in partnership with the company's management. Tecomet was previously a portfolio company of Charlesbank Capital Partners.

Founded in 1964 and based in Wilmington, MA, Tecomet manufactures orthopedic implants, precision surgical instruments, trauma plates and photochemical etched products for medical device customers. Tecomet uses its industry-leading prototyping and engineering capabilities to produce highly complex products that provide innovative solutions for its customers' most demanding products and applications. Tecomet is also a leading manufacturer of precision components to the aerospace & defense industry, producing products used in missile & satellite propulsion systems, vision systems, and infrared applications.

Genstar will partner with the Tecomet management team including Bill Dow and John Connolly to continue the company's impressive growth trajectory. Bill Dow, Tecomet's CEO, said, "Tecomet has become a trusted partner for our customers by providing differentiated manufacturing capabilities combined with industry-leading quality and reliability. We look forward to our partnership with Genstar as we share a similar vision towards continuing Tecomet's growth both organically and through acquisitions.  Genstar has a proven track record of growing companies in the industrial and healthcare industries and we are excited to utilize their capital, expertise and network to help Tecomet accelerate its growth."             

Rob Rutledge, Principal at Genstar Capital, said, "Tecomet is led by an outstanding management team that we are excited to partner with.  Bill Dow, John Connolly and the rest of Tecomet's employees have built the company into one of the premier precision manufacturers for the medical device and aerospace & defense industries, driving growth both organically and through the sourcing and integration of strategic acquisitions.  Genstar is eager to partner with the Tecomet management team to expand the company's capabilities, product offering and geographic reach while continuing to provide excellent quality and service to its customers." 

About Genstar Capital Management, LLC
Genstar Capital (www.gencap.com) is a leading private equity firm that has been actively investing in high quality companies for 25 years. Based in San Francisco, Genstar works in partnership with its management teams and its network of operating executives and strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar has more than $4 billion of committed capital under management and targets investments focused on selected sectors within the industrial technology, healthcare, financial services and software industries.

Contact: Chris Tofalli
Chris Tofalli Public Relations
914-834-4334


'/>"/>
SOURCE Genstar
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Genstar Capital Completes ERT Acquisition In A Take-Private Transaction
2. PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital
3. Savient Pharmaceuticals Receives Favorable Decision In Tang Capital Litigation
4. Intrepid Investment Bankers LLC Advises A-Med Health Care in the Sale of its Specialty Pharmacy Assets to Modern HC Pharmacy, Inc., a portfolio company of Altamont Capital Partners
5. Neuralstem Announces Exercise Of Entire Over-Allotment Option By Aegis Capital Corp.
6. Physicians Capital Investments, Physicians Capital Markets, and EDGE Realty Capital Markets announce a new strategic initiative
7. Savient Pharmaceuticals to Present at the 6th Annual Imperial Capital Global Opportunities Conference
8. Innophos To Present At 2012 KeyBanc Capital Markets Basic Materials & Packaging Conference
9. GP Strategies to Present at the BMO Capital Markets 12th Annual Back to School Education Conference
10. Raging Capital Calls On Taro Pharmaceutical Shareholders To Vote Against The Taro / Sun Pharma Merger
11. Masimo to Present at Lazard Capital Markets 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical Center ... in Nashville , Tennesse have been ... Sphincter Stimulation for GERD (LESS GERD) trial. The EndoStim ... long-term reflux control by restoring normal function to the ... million people in the United States ...
(Date:4/19/2017)... N.J. , April 19, 2017  Novartis ... by the National Heart, Lung, and Blood Institute ... demonstrating that 58% of patients with treatment-naïve severe ... months when treated with eltrombopag at the initiation ... . The study evaluated three sequential treatment groups, ...
(Date:4/18/2017)... April 18, 2017 Research and Markets has ... report to their offering. ... The global arthroscopy devices market to grow at a CAGR of ... Arthroscopy Devices Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
Breaking Medicine Technology:
(Date:4/25/2017)... Vegas, NV (PRWEB) , ... April 25, 2017 ... ... can now choose a modern procedure that achieves results in a fraction of ... in Las Vegas, NV, with Significance Dental Specialists, now offers this revolutionary ...
(Date:4/25/2017)... ... , ... Back Pain Centers of America (BPC), which connects people ... their area, announces the launch of a new and proprietary customer relationship management (CRM) ... reputable physicians to help them with back or neck pain and helps to match ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... predictive analytics to its patient care management module. Using this new feature, sleep ... patient has been initiated on continuous positive airway pressure (CPAP), oral, or other ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG CNS Healthcare ... Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national conference. , ... medical devices with a pre-programmed tablet in a remarkably easy-to-use kit for patients. ...
Breaking Medicine News(10 mins):